RPh201, botanical drug product

DRUG3 trials

Sponsors

Regenera Pharma Ltd

Conditions

Chronic WoundHealthy VolunteersModerate to Severe Alzheimer PatientsPartial Thickness BurnSecond Degree Burn Less Than 5%TBSA

Phase 1

Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds

TerminatedNCT01429519

Regenera Pharma LtdChronic Wound

Start: 2011-12-31End: 2012-12-31Updated: 2018-09-04

Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn

WithdrawnNCT01455480

Regenera Pharma LtdPartial Thickness Burn, Second Degree Burn Less Than 5%TBSA

Start: 2011-12-31End: 2011-12-31Updated: 2016-12-06

A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

CompletedNCT01513967

Regenera Pharma LtdHealthy Volunteers, Moderate to Severe Alzheimer Patients

Start: 2012-01-31End: 2015-06-30Updated: 2020-03-23